...
【24h】

In reply

机译:回复

获取原文
获取原文并翻译 | 示例
           

摘要

In reply It is nice to see the correspondence and interest of Michael Alexiou, MD. He brings up several excellent points, and it is a pleasure to respond. First, the point of our study1 is to recognize that when Mohs surgery is not performed, perhaps a slightly larger margin should be obtained during primary gross excision. It does not claim that Mohs surgery is always indicated.Dr Alexiou's letter challenges Mohs surgery as the gold standard for skin cancer excision. To that end, I will attempt to address his points. There is no question that all surgeons are not the same in ability. Having said that, however, one must assume that we all have the patient's best interest in mind and would like nothing more than to have the cancer completely excised at first go-round. Good lighting and loupe magnification certainly make sense, but I hope he is not insinuating that they compare with the microscope in terms of identifying tumor margins. Mohs surgeons remove skin cancer, all day, every day, for a career, and yet they still occasionally underestimate clinical tumor extent. One cannot compare the 2 techniques (Mohs surgery vs frozen section control) in terms of percentage of specimen margin that is analyzed histopathologically. Furthermore, excellent cure rates are not the only advantage of Mohs surgery. An aggressive surgical margin on all nodular basal cell carcinomas would likely diminish the recurrence rate to well less than 1%. Mohs surgery achieves high cure rates while maximizing tissue preservation, a paramount consideration on the face. With regards to time, I am not sure a routine visit to the Mohs surgeon is much longer than an operative visit in which frozen sections are being obtained, as Dr Alexiou suggests. The fact that a Mohs surgeon cannot close all cutaneous defects is not a reason to avoid them; it leads to interdisciplinary patient care. Collaboration between the primary dermatologist, Mohs surgeon, plastic surgeon, oculoplastic surgeon, and facial plastic surgeon should be the "gold standard."
机译:回复很高兴看到医学博士Michael Alexiou的来信和兴趣。他提出了几个要点,很高兴做出回应。首先,我们的研究重点是要认识到,如果不进行Mohs手术,则在初次大体切除时应获得稍大的切缘。并不是说总是要进行Mohs手术。Alexiou博士的信挑战了Mohs手术作为皮肤癌切除术的金标准。为此,我将尝试解决他的观点。毫无疑问,所有外科医生的能力都不相同。话虽这么说,但必须假设我们都怀念着患者的最大利益,并且只希望在第一轮手术中彻底切除癌症即可。良好的照明和放大镜放大倍率当然是有道理的,但我希望他不要暗示它们在确定肿瘤边缘方面可以与显微镜进行比较。莫氏外科医师整天,每天为职业生涯去除皮肤癌,但他们偶尔仍会低估临床肿瘤的程度。一个人不能用组织病理学分析的标本切缘百分比来比较这两种技术(莫氏手术与冷冻切片对照)。此外,出色的治愈率并不是莫氏手术的唯一优势。在所有结节性基底细胞癌上进行积极的手术切缘可能会使复发率降低至不足1%。 Mohs手术可达到高治愈率,同时最大限度地保护组织,这是面部护理的首要考虑因素。关于时间,我不确定像莫里斯外科医师的例行拜访是否会比Alexiou博士建议的进行冷冻切片的手术拜访要长得多。莫氏外科医师无法消除所有皮肤缺陷的事实,并不是避免这些缺陷的理由。它导致了跨学科的患者护理。主要的皮肤科医生,莫氏外科医师,整形外科医师,眼部整形外科医师和面部整形外科医师之间的合作应该是“黄金标准”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号